O-2390

Synthetic cannabinoid

O-2390
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

O-2390 is a synthetic cannabinoid that was developed in the 1990s. It is a potent and selective agonist for the cannabinoid receptor CB₁, which is primarily found in the central nervous system.

Chemical Structure

O-2390 is a derivative of the classical cannabinoid structure, featuring a dibenzopyran ring system. The compound is characterized by the presence of a 1,1-dimethylheptyl side chain, which is known to enhance its potency at the CB₁ receptor. The stereochemistry of O-2390 is defined by its (6aR,10aR) configuration, which is crucial for its activity.

Pharmacology

O-2390 acts as a full agonist at the CB₁ receptor, which is a G protein-coupled receptor (GPCR) involved in the modulation of neurotransmitter release. Activation of CB₁ receptors by O-2390 leads to a variety of effects, including analgesia, appetite stimulation, and alterations in mood and perception. The compound's high affinity and selectivity for CB₁ make it a valuable tool for studying the physiological roles of cannabinoid receptors.

Synthesis

The synthesis of O-2390 involves the modification of the dibenzopyran core structure, with specific attention to the introduction of the 1,1-dimethylheptyl side chain. The synthetic route typically involves multiple steps, including the formation of the pyran ring and the subsequent functionalization to achieve the desired stereochemistry and side chain.

Applications

O-2390 is primarily used in research settings to investigate the function of cannabinoid receptors. Its ability to selectively activate CB₁ receptors makes it a useful compound for exploring the endocannabinoid system and its role in various physiological and pathological processes.

Legal Status

As a synthetic cannabinoid, O-2390 may be subject to legal restrictions in some jurisdictions. Its use is generally confined to scientific research, and it is not approved for medical use in humans.

Related pages

• Cannabinoid receptor
• Endocannabinoid system
• Synthetic cannabinoids